These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15863819)

  • 21. Pilocarpine in the prevention of postirradiation xerostomia.
    Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
    Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
    Nakamura N; Sasano N; Yamashita H; Igaki H; Shiraishi K; Terahara A; Asakage T; Nakao K; Ebihara Y; Ohtomo K; Nakagawa K
    Auris Nasus Larynx; 2009 Jun; 36(3):310-3. PubMed ID: 18635328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cevimeline (Evoxac) for dry mouth.
    Med Lett Drugs Ther; 2000 Aug; 42(1084):70. PubMed ID: 10932302
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
    Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
    J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
    Sangthawan D; Watthanaarpornchai S; Phungrassami T
    J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug used during radiotherapy helps reduce dry mouth problem.
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):4. PubMed ID: 12113130
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influencing of xerostomia and asialia during psychotropic drug therapy with benzopyrone].
    Beck-Steiner G
    MMW Munch Med Wochenschr; 1979 Apr; 121(16):569-70. PubMed ID: 111051
    [No Abstract]   [Full Text] [Related]  

  • 28. Pilocarpine toxicity and the treatment of xerostomia.
    Hendrickson RG; Morocco AP; Greenberg MI
    J Emerg Med; 2004 May; 26(4):429-32. PubMed ID: 15093850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xerostomia. Absence makes the mouth get drier.
    Harv Health Lett; 2000 May; 25(7):7. PubMed ID: 10760968
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of pilocarpine hydrochloride and cevimeline on submandibular/sublingual salivation in rat xerostomia model produced by X-ray irradiation.
    Omori Y; Asari T; Maruyama K; Kusama H; Kojima M; Shibata N
    Arzneimittelforschung; 2003; 53(5):342-50. PubMed ID: 12854361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xerostomia: a clinical approach.
    Lewis DM
    J Okla Dent Assoc; 2005 Oct; 97(2):22-5. PubMed ID: 16296424
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of dryness of the mouth induced by psychopharmacological drugs].
    Lingjaerde O
    Tidsskr Nor Laegeforen; 1969 Feb; 89(3):188-90. PubMed ID: 4978561
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparing the effectiveness and adverse effects of pilocarpine and cevimeline in patients with hyposalivation.
    Farag AM; Holliday C; Cimmino J; Roomian T; Papas A
    Oral Dis; 2019 Nov; 25(8):1937-1944. PubMed ID: 31520497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the use of sialogogues in the clinical management of patients with xerostomia.
    Chainani-Wu N; Gorsky M; Mayer P; Bostrom A; Epstein JB; Silverman S
    Spec Care Dentist; 2006; 26(4):164-70. PubMed ID: 16927740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing radiation induced xerostomia.
    Koukourakis MI; Danielidis V
    Cancer Treat Rev; 2005 Nov; 31(7):546-54. PubMed ID: 16257125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial.
    Mouly SJ; Orler JB; Tillet Y; Coudert AC; Oberli F; Preshaw P; Bergmann JF
    J Clin Psychopharmacol; 2007 Oct; 27(5):437-43. PubMed ID: 17873673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.
    Chambers MS; Keene HJ; Toth BB; Lemon JC; Gallagher SC; Martin CG; Martin JW
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):180-4. PubMed ID: 15660089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New therapeutic strategies for xerostomia in chronic graft versus host disease patients].
    Nagler R
    Harefuah; 2000 Jun; 138(12):1061-4. PubMed ID: 10979435
    [No Abstract]   [Full Text] [Related]  

  • 39. New approaches to preventing xerostomia.
    J Support Oncol; 2006 Feb; 4(2):87-8. PubMed ID: 16499130
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial.
    Chitapanarux I; Kamnerdsupaphon P; Tharavichitkul E; Sumitsawan Y; Sittitrai P; Pattarasakulchai T; Lorvidhaya V; Sukthomya V; Pukanhaphan N; Traisatit P
    J Med Assoc Thai; 2008 Sep; 91(9):1410-5. PubMed ID: 18843872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.